Skip to Content

GSI 3 (Vosevi sofosbuvir 400 mg / velpatasvir 100 mg / voxilaprevir 100 mg)

Generic Name: sofosbuvir/velpatasvir/voxilaprevir

Pill with imprint GSI 3 is Beige, Capsule-shape and has been identified as Vosevi sofosbuvir 400 mg / velpatasvir 100 mg / voxilaprevir 100 mg. It is supplied by Gilead Sciences, Inc..

Vosevi is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Vosevi sofosbuvir 400 mg / velpatasvir 100 mg / voxilaprevir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 3

Vosevi

Generic Name:
sofosbuvir/velpatasvir/voxilaprevir
Imprint:
GSI 3
Strength:
sofosbuvir 400 mg / velpatasvir 100 mg / voxilaprevir 100 mg
Color:
Beige
Size:
20.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-2401
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide